Risk Assessment of Cardiovascular Disease in HIV Infected Individuals Receiving Antiretroviral Therapy - Shanghai Municipality, China, 2023.

What is already known about this topic?: Antiretroviral therapy (ART) is transforming human immunodeficiency virus (HIV) infection into a chronic condition, leading to an altered disease spectrum in patients. The risk of cardiovascular disease (CVD) in HIV-infected individuals are twice that of the general population.

What is added by this report?: This study demonstrates elevated cardiovascular risk among the HIV population. The findings reveal that traditional CVD risk factors are prevalent among people living with HIV but remain inadequately addressed in clinical practice.

What are the implications for public health practice?: These findings underscore both the necessity and urgency of implementing systematic CVD risk screening and intervention programs for HIV population. Furthermore, the study emphasizes the critical need to develop CVD screening tools specifically calibrated for the HIV population in China.